Navigation Links
GeneWize Announces New Skin Clearing Product and Teen Nutrition at Annual Convention
Date:10/7/2010

ORLANDO, Fla., Oct. 7 /PRNewswire/ -- GeneWize Life Sciences www.genewize.com, a subsidiary of GeneLink BioSciences (OTC Bulletin Board: GNLK) announced before a full house of independent GeneWize Wellness Entrepreneurs a new product category targeting the teen market, adding to their current flagship products of DNA-personalized nutrition and skin care.

The new nutrition and skin-clearing products, aimed at the 11-17 year-old age group, were designed by leading doctors, genetic scientists and dietary researchers.  The new products include:

LifeMap YGLT (You're Gonna Love This!) Anti-Acne Skin Serum

  • The first all natural, organic and 100% safe anti-acne product:  No harsh Benzoil Peroxide or other chemicals as in leading acne treatments.
  • Most effective, all natural "acne-active" ingredients available.  Works on the source of the problem to help skin provide a defense against acne and other teen skin problems.
  • Penetrates deep into pores to help clear acne fast
  • Provides 30 different key skin nutrients, vitamins & minerals

LifeMap YGLT (You're Gonna Love This!) Nutrition for Teens

  • Contains the equivalent nutrients of 4 – 6 servings of fruits and vegetables
  • Vitamins A, B, C, D and K, along with essential minerals including calcium for the critical body-growth years
  • Vitamin and Nutritional Supplement ingredients are validated by independent third-party research

About GeneWize Life Sciences:

GeneWize is the direct selling subsidiary of GeneLink BioSciences, a 16 year-old pioneer in Genetically-Guided Wellness.  The GeneWize mission is to make wellness & beauty possible by making it personal- and in doing so, give families an income opportunity providing financial security and personal growth.  Its products are backed by 16 years of research, multiple patented technologies and are manufactured in the USA from the highest quality, freshest ingredients each month and then shipped directly to the consumer.  For more information, go to www.genewize.com.

About GeneLink BioSciences:

GeneLink is a publicly trades (GNLK.OB) genomics, biotechnology, and wellness company engaged in genetic test development, product development, and manufacturing of personalized vitamin, nutritional supplement, and skin care wellness products.  For additional information, please visit www.genelinkbio.com.


'/>"/>
SOURCE GeneWize Life Sciences
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results
2. Odyssey Thera Announces Milestone Achievement in Pfizer Alliance
3. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
4. Anesiva Announces Second Quarter 2008 Financial Results and Update
5. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
6. Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008
7. China Sky One Medical, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
8. China Yingxia International, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
9. ThirdBiotech Announces Kemeta as Newest Sponsor
10. Signalife Announces Intent to Withdraw From AMEX and Trade on the OTCBB
11. Chromos obtains interim order in connection with arrangement, announces annual and special meeting of shareholders and confirms mailing of information circular
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... ... and Mold) microbial test has received AOAC Research Institute approval 061601. , “This ... introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. ...
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... ... ... In a new case report published today in STEM CELLS Translational Medicine, ... after being treated for breast cancer benefitted from an injection of stem cells derived ... debilitating, frequent side effect of cancer treatment. , Lymphedema refers to the ...
(Date:6/23/2016)... -- Andrew D Zelenetz , ... Published recently in Oncology & ... Andrew D Zelenetz , discusses the fact ... placing an increasing burden on healthcare systems worldwide, ... the patents on many biologics expiring, interest in ...
Breaking Biology Technology:
(Date:6/21/2016)... 2016 NuData Security announced today that Randy ... principal product architect and that Jon Cunningham ... development. Both will report directly to Christopher ... reflect NuData,s strategic growth in its product and ... demand and customer focus values. ...
(Date:6/16/2016)... June 16, 2016 The ... expected to reach USD 1.83 billion by 2024, ... Research, Inc. Technological proliferation and increasing demand in ... expected to drive the market growth. ... The development of advanced multimodal techniques for ...
(Date:6/9/2016)...  Perkotek an innovation leader in attendance control systems is proud to announce the ... employers to make sure the right employees are actually signing in, and to even ... ... ... ...
Breaking Biology News(10 mins):